In one study, melanoma-derived EV have been demonstrated to skew monocyte differentiation towards suppressive CD14+HLA-DR-/low cells, which also lose the expression of costimulatory molecules CD80 and CD86 [68]. This evidence concerns the gene CD14 and melanoma.